EXCEED THE SPACE PROVIDED. The overall goal of the Nephrology Training Program at Massachusetts General Hospital is to develop highly committed MDs and/or PhDs into mature, broadly educated and independent scientists who will pursue research careers in academic nephrology. The major component of this renewed program is the training of eight postdoctoral fellows annually in the conduct of basic or clinical-based research, under supervision of established investigators serving as mentors, in well-equipped research facilities supported by state-of-the-art core services. Bench work is complemented by didactic instruction and enrichment activities. Intensive training in basic or clinical research is provided by senior and junior faculty preceptors, in a multidisciplinary environment conducive of collaborative interactions among groups. There are ample opportunities for training in several disciplines including membrane biology, biophysics, genetics, genomics, immunology, transplantation biology, inflammation, kidney development, biochemistry, cell signaling, structural biology and outcomes and epidemiology research. These disciplines are applied to nine research themes central to the study of kidney disease. These approaches are applied in many cases to clinically relevant diseases such as nephritis, acute renal failure, electrolyte disorders, polycystic kidney disease, bioincompatibility, allograft rejection, vasculitis and progressive renal dysfunction. Didactic instruction through courses and weekly lectures offered at Massachusetts General Hospital, Harvard Medical School, Harvard School of Public Health or Harvard College complements bench training. Courses in biostatistics, epidemiology, clinical effectiveness and outcomes research are offered for fellows pursuing careers in clinical investigation. All research trainees are required to participate in an annual course in the responsible conduct of research. A recently established Society of Fellows at Massachusetts General Hospital serves to introduce fellows to each other, and offers lectures on grant writing, bioethics, conflict resolution, job hunting, and time management in two career families. PERFORMANCE SITE ========================================Section End===========================================

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Rankin, Tracy L
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Massachusetts General Hospital
United States
Zip Code
Poyan Mehr, Ali; Tran, Mei T; Ralto, Kenneth M et al. (2018) De novo NAD+ biosynthetic impairment in acute kidney injury in humans. Nat Med 24:1351-1359
Lim, Kenneth; Hamano, Takayuki; Thadhani, Ravi (2018) Vitamin D and Calcimimetics in Cardiovascular Disease. Semin Nephrol 38:251-266
Nguyen, Hai Dang; Leong, Wan Yee; Li, Weiling et al. (2018) Spliceosome Mutations Induce R Loop-Associated Sensitivity to ATR Inhibition in Myelodysplastic Syndromes. Cancer Res 78:5363-5374
Pang, Paul; Abbott, Molly; Abdi, Malyun et al. (2018) Pre-clinical model of severe glutathione peroxidase-3 deficiency and chronic kidney disease results in coronary artery thrombosis and depressed left ventricular function. Nephrol Dial Transplant 33:923-934
Kabeche, Lilian; Nguyen, Hai Dang; Buisson, RĂ©mi et al. (2018) A mitosis-specific and R loop-driven ATR pathway promotes faithful chromosome segregation. Science 359:108-114
Canali, Susanna; Zumbrennen-Bullough, Kimberly B; Core, Amanda B et al. (2017) Endothelial cells produce bone morphogenetic protein 6 required for iron homeostasis in mice. Blood 129:405-414
Nguyen, Hai Dang; Yadav, Tribhuwan; Giri, Sumanprava et al. (2017) Functions of Replication Protein A as a Sensor of R Loops and a Regulator of RNaseH1. Mol Cell 65:832-847.e4
Cortazar, Frank B; Leaf, David E; Owens, Charles T et al. (2017) Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series. BMC Nephrol 18:44
Cortazar, Frank B; Pendergraft 3rd, William F; Wenger, Julia et al. (2017) Effect of Continuous B Cell Depletion With Rituximab on Pathogenic Autoantibodies and Total IgG Levels in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Rheumatol 69:1045-1053
Olabisi, Opeyemi A; Heneghan, John F (2017) APOL1 Nephrotoxicity: What Does Ion Transport Have to Do With It? Semin Nephrol 37:546-551

Showing the most recent 10 out of 78 publications